290 related articles for article (PubMed ID: 16167351)
61. Role of prohormone convertases in pro-neuropeptide Y processing: coexpression and in vitro kinetic investigations.
Brakch N; Rist B; Beck-Sickinger AG; Goenaga J; Wittek R; Bürger E; Brunner HR; Grouzmann E
Biochemistry; 1997 Dec; 36(51):16309-20. PubMed ID: 9405066
[TBL] [Abstract][Full Text] [Related]
62. Regulation of matrix metalloproteinase MT1-MMP/MMP-2 in cardiac fibroblasts by TGF-beta1 involves furin-convertase.
Stawowy P; Margeta C; Kallisch H; Seidah NG; Chrétien M; Fleck E; Graf K
Cardiovasc Res; 2004 Jul; 63(1):87-97. PubMed ID: 15194465
[TBL] [Abstract][Full Text] [Related]
63. Specific and Selective Inhibitors of Proprotein Convertases Engineered by Transferring Serpin B8 Reactive-Site and Exosite Determinants of Reactivity to the Serpin α1PDX.
Izaguirre G; Arciniega M; Quezada AG
Biochemistry; 2019 Mar; 58(12):1679-1688. PubMed ID: 30848586
[TBL] [Abstract][Full Text] [Related]
64. Epigenetic regulation of proprotein convertase PACE4 gene expression in human ovarian cancer cells.
Fu Y; Campbell EJ; Shepherd TG; Nachtigal MW
Mol Cancer Res; 2003 Jun; 1(8):569-76. PubMed ID: 12805404
[TBL] [Abstract][Full Text] [Related]
65. Processing of alpha4 integrin by the proprotein convertases: histidine at position P6 regulates cleavage.
Bergeron E; Basak A; Decroly E; Seidah NG
Biochem J; 2003 Jul; 373(Pt 2):475-84. PubMed ID: 12691605
[TBL] [Abstract][Full Text] [Related]
66. Proprotein convertases regulate insulin-like growth factor 1-induced membrane-type 1 matrix metalloproteinase in VSMCs via endoproteolytic activation of the insulin-like growth factor-1 receptor.
Stawowy P; Kallisch H; Kilimnik A; Margeta C; Seidah NG; Chrétien M; Fleck E; Graf K
Biochem Biophys Res Commun; 2004 Aug; 321(3):531-8. PubMed ID: 15358140
[TBL] [Abstract][Full Text] [Related]
67. Engineering of alpha1-antitrypsin variants selective for subtilisin-like proprotein convertases PACE4 and PC6: importance of the P2' residue in stable complex formation of the serpin with proprotein convertase.
Tsuji A; Kanie H; Makise H; Yuasa K; Nagahama M; Matsuda Y
Protein Eng Des Sel; 2007 Apr; 20(4):163-70. PubMed ID: 17351018
[TBL] [Abstract][Full Text] [Related]
68. Immunohistochemical localization of subtilisin/kexin-like proprotein convertases in human atherosclerosis.
Stawowy P; Kallisch H; Borges Pereira Stawowy N; Stibenz D; Veinot JP; Gräfe M; Seidah NG; Chrétien M; Fleck E; Graf K
Virchows Arch; 2005 Apr; 446(4):351-9. PubMed ID: 15756593
[TBL] [Abstract][Full Text] [Related]
69. Potent inhibitors of furin and furin-like proprotein convertases containing decarboxylated P1 arginine mimetics.
Becker GL; Sielaff F; Than ME; Lindberg I; Routhier S; Day R; Lu Y; Garten W; Steinmetzer T
J Med Chem; 2010 Feb; 53(3):1067-75. PubMed ID: 20038105
[TBL] [Abstract][Full Text] [Related]
70. Processing of cocaine- and amphetamine-regulated transcript (CART) precursor proteins by prohormone convertases (PCs) and its implications.
Stein J; Steiner DF; Dey A
Peptides; 2006 Aug; 27(8):1919-25. PubMed ID: 16784796
[TBL] [Abstract][Full Text] [Related]
71. Proprotein convertases: Key players in inflammation-related malignancies and metastasis.
Siegfried G; Descarpentrie J; Evrard S; Khatib AM
Cancer Lett; 2020 Mar; 473():50-61. PubMed ID: 31899298
[TBL] [Abstract][Full Text] [Related]
72. Proprotein convertases furin and PC5: targeting atherosclerosis and restenosis at multiple levels.
Stawowy P; Fleck E
J Mol Med (Berl); 2005 Nov; 83(11):865-75. PubMed ID: 16244876
[TBL] [Abstract][Full Text] [Related]
73. Proprotein convertase genes in Xenopus development.
Nelsen S; Berg L; Wong C; Christian JL
Dev Dyn; 2005 Jul; 233(3):1038-44. PubMed ID: 15844195
[TBL] [Abstract][Full Text] [Related]
74. Liver-Specific Inactivation of the Proprotein Convertase FURIN Leads to Increased Hepatocellular Carcinoma Growth.
Declercq J; Brouwers B; Pruniau VP; Stijnen P; Tuand K; Meulemans S; Prat A; Seidah NG; Khatib AM; Creemers JW
Biomed Res Int; 2015; 2015():148651. PubMed ID: 26167473
[TBL] [Abstract][Full Text] [Related]
75. Proprotein convertases in tumor progression and malignancy: novel targets in cancer therapy.
Khatib AM; Siegfried G; Chrétien M; Metrakos P; Seidah NG
Am J Pathol; 2002 Jun; 160(6):1921-35. PubMed ID: 12057895
[TBL] [Abstract][Full Text] [Related]
76. The possible role furin and furin inhibitors in endometrial adenocarcinoma: A narrative review.
Al-Kuraishy HM; Al-Maiahy TJ; Al-Gareeb AI; Alexiou A; Papadakis M; Saad HM; Batiha GE
Cancer Rep (Hoboken); 2024 Jan; 7(1):e1920. PubMed ID: 38018319
[TBL] [Abstract][Full Text] [Related]
77. Malignant conversion of non-tumorigenic murine skin keratinocytes overexpressing PACE4.
Mahloogi H; Bassi DE; Klein-Szanto AJ
Carcinogenesis; 2002 Apr; 23(4):565-72. PubMed ID: 11960907
[TBL] [Abstract][Full Text] [Related]
78. Inactivation of Proprotein Convertases in T Cells Inhibits PD-1 Expression and Creates a Favorable Immune Microenvironment in Colorectal Cancer.
Tomé M; Pappalardo A; Soulet F; López JJ; Olaizola J; Leger Y; Dubreuil M; Mouchard A; Fessart D; Delom F; Pitard V; Bechade D; Fonck M; Rosado JA; Ghiringhelli F; Déchanet-Merville J; Soubeyran I; Siegfried G; Evrard S; Khatib AM
Cancer Res; 2019 Oct; 79(19):5008-5021. PubMed ID: 31358531
[TBL] [Abstract][Full Text] [Related]
79. Biosynthesis of peptide hormones derived from precursor sequences.
von Eggelkraut-Gottanka R; Beck-Sickinger AG
Curr Med Chem; 2004 Oct; 11(20):2651-65. PubMed ID: 15544467
[TBL] [Abstract][Full Text] [Related]
80. Novel insights into cadherin processing by subtilisin-like convertases.
Posthaus H; Dubois CM; Müller E
FEBS Lett; 2003 Feb; 536(1-3):203-8. PubMed ID: 12586364
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
